stocksNORRIS
NORRIS

Norris Medicines Ltd.

15.01+0.0 (+0.07%)
23 Oct, 12:00 AM

Annual Reports and Financial Documents

Norris Medicines Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.
201520162017201820192020202120222023202420252026
Annual ReportsFY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Quarterly Results————
Conference Calls————————————
Presentations————————————

Corporate Announcements and Regulatory Filings

Norris Medicines Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.
  1. Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 201812 Oct 2026
    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
    Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended 30th September, 2026
  2. General29 Sept 2026
    Scrutinizer''s Report And Voting Results Of The 35Th AGM Of The Company Held 29Th September, 2026
    Scrutinizer''s Report and Voting Results of the 35th Annual General Meeting of the Company held on Tuesday 29th September, 2026
  3. AGM29 Sept 2026
    Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
    Scrutinizer''s Report and Voting Results of the 35th Annual General Meeting of the Company held on Tuesday 29th September, 2026
  4. General29 Sept 2026
    Outcome And Proceeding Of The 35Th Annual General Meeting
    Outcome and proceeding of the 35th Annual General Meeting of the Company held on Tuesday 29th September, 2026
  5. AGM29 Sept 2026
    Proceeding Of The Annual General Meeting
    Outcome and proceeding of the 35th Annual General Meeting of the Company held on Tuesday 29th September, 2026
  6. AGM29 Sept 2026
    Shareholder Meeting / Postal Ballot-Outcome of AGM
    Outcome of 35th Annual General Meeting of the Company held on Tuesday, 29th September, 2026
  7. Closure of Trading Window26 Sept 2026
    Closure of Trading Window
    Intimation of Closure of Trading Window
  8. Newspaper Publication7 Sept 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Newspaper advertisement regarding the 35th Annual General Meeting of the Company.
  9. Reg. 34 (1) Annual Report4 Sept 2026
    Reg. 34 (1) Annual Report.
    Annual Report of the Company for the Financial year 2025-26.
  10. AGM4 Sept 2026
    Notice Of 35Th Annual General Meeting Of The Company For The Financial Year 2025-26
    Notice of 35th Annual General Meeting of the Company for the Financial Year 2025-26
  11. Book Closure4 Sept 2026
    Intimation Of Book Closure For 35Th AGM Of The Company.
    Intimation of Book Closure for 35th AGM of the Company
  12. Outcome without intimation3 Sept 2026
    Board Meeting Outcome for Of Board Meeting Held On Thurday, 03Rd September, 2026 Pursuant To Regulation 30 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015.
    Outcome of the Board Meeting on Thursday, 03rd September, 2026 pursuant to Regulation 30 of the SEBI(LODR) Regulations, 2015
  13. Change in Management14 Aug 2026
    Announcement under Regulation 30 (LODR)-Change in Management
    Appointment of Mr. Vimal Dhirendra Shah (DIN: 01506655) as a Managing Director (Promoter and Executive) of the Company for a term of 3 (Three) consecutive years effective from 1st September, ....
  14. Outcome of Board Meeting14 Aug 2026
    Board Meeting Outcome for Outcome Of Board Meeting Held On August 14, 2026, Pursuant To Regulation 30 And Regulation 33 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015.
    Board Meeting held on August 14, 2026 for the quarter ended June 30, 2026.
  15. Board Meeting8 Aug 2026
    Board Meeting Intimation for Under Regulation 29 Of SEBI Listing Obligation And Disclosure Requirements, 2015 For Holding Board Meeting For Approval Of Un-Audited Financial Results For The Quarter Ended June 30, 2026
    Norris Medicines Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider and approve Unaudited Financial Results ....
  16. Change in Management30 Jul 2026
    Announcement under Regulation 30 (LODR)-Change in Management
    Intimation relating to appointment of Mr. Iqubal Ismail Patel as Chief Financial Officer (CFO) & Key Managerial Personnel (KMP) of the Company in the meeting of the Board dated 30th July, 2026.
  17. Outcome without intimation30 Jul 2026
    Board Meeting Outcome for Outcome Of The Board Meeting Dated 30Th July, 2026.
    Outcome of Board Meeting held on Thursday, July 30, 2026 pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
  18. General3 Jul 2026
    Certificate Under Reg. 74 (5) Of SEBI (DP) Regulations, 2018
    Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations 2018 for the quarter ended 30 June, 2026.
  19. Closure of Trading Window24 Jun 2026
    Closure of Trading Window
    Intimation for Closure of Trading Window
  20. Change in Management30 May 2026
    Announcement under Regulation 30 (LODR)-Change in Management
    Appointment of Internal Auditor w.e.f 30.05.2026

Frequently Asked Questions

Where can I download the annual report of Norris Medicines Ltd.?
Annual reports of Norris Medicines Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.
Where can I find the quarterly results of Norris Medicines Ltd.?
Quarterly earnings results and presentations of Norris Medicines Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.
Does Norris Medicines Ltd. publish earnings call transcripts?
Earnings call transcripts of Norris Medicines Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.
Where can I find investor presentations of Norris Medicines Ltd.?
Investor presentations and annual day presentations of Norris Medicines Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.
What are the recent corporate announcements of Norris Medicines Ltd.?
Corporate announcements and regulatory filings of Norris Medicines Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.
How do I access the regulatory filings of Norris Medicines Ltd.?
Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Norris Medicines Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.
What is the ISIN of Norris Medicines Ltd.?
The ISIN (International Securities Identification Number) of Norris Medicines Ltd. is INE744C01029. This is the unique identifier used across exchanges and depositories.
On which stock exchange is Norris Medicines Ltd. listed?
Norris Medicines Ltd. is listed on NSE and BSE. The NSE symbol is NORRIS and the BSE code is -.
Where can I find the shareholding pattern of Norris Medicines Ltd.?
The quarterly shareholding pattern of Norris Medicines Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.
How current is the data for Norris Medicines Ltd. on Sharpely?
Share price data for Norris Medicines Ltd. is updated as of 23 Oct 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.